A Growing Body
of Evidence
Browse the expanding collection of published research featuring our seed amplification assay (SAA) technology.

Scientific Paper
The Lancet Neurology
Unlocking the full clinical potential of the α-synuclein seed amplification assay

July 1, 2025
Read MoreScientific Paper
The Lancet Neurology
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study

July 1, 2025
Read MoreScientific Paper
Brain
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients

January 31, 2025
Read MoreScientific Paper
Journal of Movement Disorders
Cardiac 123I-meta-iodobenzylguanidine Imaging as a Biomarker for Body-first Parkinson’s Disease: Linking Peripheral α-Synuclein to Clinical Subtyping

August 4, 2025
Read MoreScientific Paper
Nature Communications
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification

August 5, 2025
Read MoreScientific Paper
npj Parkinson's Disease
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy

August 7, 2025
Read MoreScientific Paper
Movement Disorders
Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism

August 20, 2025
Read MoreScientific Paper
Annals of Neurology
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder

July 11, 2025
Read MoreScientific Paper
eBioMedicine
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort

September 1, 2025
Read MoreScientific Paper
Movement Disorders Clinical Practice
Prodromal Lewy Body Symptoms and α-Synuclein Seeding in Idiopathic Olfactory Dysfunction

September 8, 2025
Read MoreScientific Paper
Journal of Neurology
Longitudinal decline in striatal DAT binding in LRRK2 Parkinson's disease: connections with CSF α-synuclein seeding activity

September 13, 2025
Read MoreScientific Paper
Neurology
α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment Performance and Interactions With CSF and Plasma Biomarkers

October 7, 2025
Read MoreScientific Paper
Alzheimer's & Dementia
Self- and study partner–reported cognitive decline in older adults without dementia: The role of α-synuclein and amyloid biomarkers in the Alzheimer’s Disease Neuroimaging Initiative

September 23, 2024
Read MoreScientific Paper
Brain Communications
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization

March 6, 2025
Read MoreScientific Paper
Molecular Neurodegeneration
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease

March 18, 2025
Read MoreGet in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.